Patents by Inventor Keyue Shen

Keyue Shen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230137331
    Abstract: The present invention provides compositions and methods for activation and expansion of T cells using a biocompatible solid substrate with tunable rigidity. Rigidity of a substrate is an important parameter that can be used to control the overall expansion and differentiation of T cells.
    Type: Application
    Filed: June 13, 2022
    Publication date: May 4, 2023
    Inventors: Michael C. Milone, Lance C. Kam, Keyue Shen, Xueli Hao, Roderick O'Connor, Geraldine Goebrecht
  • Publication number: 20210040433
    Abstract: Hypoxia plays a central role in cancer progression and resistance to therapy. A microdevice platform is engineered to recapitulate the intratumor oxygen gradients that drive the heterogeneous hypoxic landscapes in solid tumors. The microdevice design features a “tumor section”-like culture by incorporating a cell layer between two diffusion barriers, where an oxygen gradient is established by cellular metabolism and physical constraints. The oxygen gradient is confirmed by numerical simulation and imaging-based oxygen sensor measurement. Spatially-resolved hypoxic signaling in cancer cells is also demonstrated through immunostaining, gene expression assay, and hypoxia-targeted drug treatment. The microdevice platform can accurately generate and control oxygen gradients, eliminates complex microfluidic handling, allows for incorporation of additional tumor components, and is compatible with high-content imaging and high-throughput applications.
    Type: Application
    Filed: October 15, 2020
    Publication date: February 11, 2021
    Inventors: KEYUE SHEN, YUTA ANDO, DANIEL YEN, HOANG TA
  • Patent number: 10829730
    Abstract: Hypoxia plays a central role in cancer progression and resistance to therapy. A microdevice platform is engineered to recapitulate the intratumor oxygen gradients that drive the heterogeneous hypoxic landscapes in solid tumors. The microdevice design features a “tumor section”-like culture by incorporating a cell layer between two diffusion barriers, where an oxygen gradient is established by cellular metabolism and physical constraints. The oxygen gradient is confirmed by numerical simulation and imaging-based oxygen sensor measurement. Spatially-resolved hypoxic signaling in cancer cells is also demonstrated through immunostaining, gene expression assay, and hypoxia-targeted drug treatment. The microdevice platform can accurately generate and control oxygen gradients, eliminates complex microfluidic handling, allows for incorporation of additional tumor components, and is compatible with high-content imaging and high-throughput applications.
    Type: Grant
    Filed: March 30, 2018
    Date of Patent: November 10, 2020
    Assignee: UNIVERSITY OF SOUTHERN CALIFORNIA
    Inventors: Keyue Shen, Yuta Ando, Daniel Yen, Hoang Ta
  • Publication number: 20180291330
    Abstract: Hypoxia plays a central role in cancer progression and resistance to therapy. A microdevice platform is engineered to recapitulate the intratumor oxygen gradients that drive the heterogeneous hypoxic landscapes in solid tumors. The microdevice design features a “tumor section”-like culture by incorporating a cell layer between two diffusion barriers, where an oxygen gradient is established by cellular metabolism and physical constraints. The oxygen gradient is confirmed by numerical simulation and imaging-based oxygen sensor measurement. Spatially-resolved hypoxic signaling in cancer cells is also demonstrated through immunostaining, gene expression assay, and hypoxia-targeted drug treatment. The microdevice platform can accurately generate and control oxygen gradients, eliminates complex microfluidic handling, allows for incorporation of additional tumor components, and is compatible with high-content imaging and high-throughput applications.
    Type: Application
    Filed: March 30, 2018
    Publication date: October 11, 2018
    Inventors: KEYUE SHEN, YUTA ANDO, DANIEL YEN, HOANG TA
  • Publication number: 20150030619
    Abstract: The present invention provides compositions and methods for activation and expansion of T cells using a biocompatible solid substrate with tunable rigidity. Rigidity of a substrate is an important parameter that can be used to control the overall expansion and differentiation of T cells.
    Type: Application
    Filed: September 6, 2012
    Publication date: January 29, 2015
    Applicant: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    Inventors: Michael C. Milone, Lance C. Kam, Keyue Shen, Hueli Hao, Roderick O'Connor, Geraldine Goebrecht
  • Publication number: 20090039073
    Abstract: Methods and devices for controlling temperature by precise heating without the need of using a temperature sensor are provided. The device comprises a resistive heating element (6), a controller (3), a heating circuit and a temperature sensing circuit. The temperature of the resistive heating element can be determined based on the resistance of the resistive heating element (6), which changes monotonically with its temperature. The resistive heating element (6) thus serves both as a heating element and as a temperature sensor, thereby obviating the need for a separate temperature sensor.
    Type: Application
    Filed: December 22, 2006
    Publication date: February 12, 2009
    Inventors: Min Guo, Keyue Shen, Cheng Zhou, Xiaosheng Guan, Jing Cheng
  • Publication number: 20080317724
    Abstract: The invention relates to methods of expanding, stimulating or activating T cells by modulating the spatial organization of signal molecules presented to the T cells.
    Type: Application
    Filed: January 18, 2008
    Publication date: December 25, 2008
    Inventors: Lance Kam, Keyue Shen, Michael L. Dustin, Vedra Kaye Thomas